Multicancer Early Detection Blood Test Performance in Cancer Survivors From the PATHFINDER Study
These findings highlight the potential of MCED tests to address a significant unmet need in long-term surveillance of survivors.
Authors
- Eric A. Klein (ORCID: https://orcid.org/0000-0002-1783-0698)
- Christina A. Clarke (ORCID: https://orcid.org/0000-0002-7515-2549)
- Margarita Lopatin (ORCID: https://orcid.org/0009-0005-7331-5577)
- Elizabeth O’Donnell (ORCID: https://orcid.org/0000-0002-4042-1526)
- Catherine R. Marinac (ORCID: https://orcid.org/0000-0002-9128-3012)
- Eric T. Fung (ORCID: https://orcid.org/0009-0008-2060-8618)
Institutions
- Menlo School (US)
- Dana-Farber Cancer Institute (US)
- Grail (United States) (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1200/po-25-00498
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00